Data from Phase III trials suggest that fidaxomicin is superior to vancomycin in preventing Clostridium difficile infection.
- Published in:
- Expert Review of Gastroenterology & Hepatology, 2010, v. 4, n. 6, p. 661
- Publication type:
- Article
Works matching DE "OPTIMER Pharmaceuticals Inc."
Results: 6
1
2
Promising Clostridium difficile treatment begins rolling regulatory submission process.
- Published in:
- Expert Review of Clinical Pharmacology, 2010, v. 3, n. 6, p. 719
- Publication type:
- Article
3
'Game changer' antibiotic and others in works for superbug.
- Published in:
- Nature Medicine, 2011, v. 17, n. 1, p. 10, doi. 10.1038/nm0111-10
- By:
- Publication type:
- Article
4
Trial watch: Phase III success for novel Clostridium difficile antibiotic.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 4, p. 260, doi. 10.1038/nrd3150
- Publication type:
- Article
5
New drug treats traveler's diarrhea: study.
- Published in:
- Romanian Journal of Medical Practice, 2008, v. 3, n. 4, p. 174
- Publication type:
- Article
6
Fidaxomicin.
- Published in:
- Drugs in R&D, 2010, v. 10, n. 1, p. 37
- Publication type:
- Article